Prevention of structural perturbation and aggregation of hepatitis B surface antigen: Screening of various additives

Pharmaceutical Development and Technology

Volumn 17, Issue 4, 2012, Pages 421-428

  Tomar, Priti ^a   Giri, Namita ^a   Karwasara, Vijai S ^a   Pandey, Ravi S ^a   Dixit, V K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Antibody titer; Antigen delivery; Hepatitis B surface antigen; Protein stabilization

Indexed keywords

DICHLOROMETHANE; HEPATITIS B SURFACE ANTIGEN; INULIN; MICROSPHERE; TREHALOSE;

ANIMAL EXPERIMENT; ANTIGEN STRUCTURE; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; CAPSULES; DRUG COMPOUNDING; EXCIPIENTS; FEMALE; HEPATITIS B SURFACE ANTIGENS; LACTIC ACID; METHYLENE CHLORIDE; MICE; MICE, INBRED BALB C; POLYGLYCOLIC ACID; PROTEIN DENATURATION; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 84862295593     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2010.546408     Document Type: Article

References (26)

1. Raghavendra C, Mundargi V, Babu R, Rangaswamy V, Patel, P, Tejraj MA.Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives.J.Cont.Rel.2008; 125: 193-209.
2. Banga A.Therapeutic Peptide and protein formulation, processing and delivery system.Technoic Lamester USA 1995; 131-163.
3. Krishnamurthy R, Lumpkin JA, Sridhar R.Inactivation of Lysozyme By sonication under condition relevant to microencapsulation.Int.J.Pharm.Res.2000; 18: 1754-1759.
4. Bharali DJ, Mousa SA, Thanavala Y.Micro- and nanoparticle-based vaccines for hepatitis B.Adv.Exp.Med.Bio.2007; 601: 415-421.
5. Jiang W, Gupta, R.K, Deshpande MC, Schwendeman SP.Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.Adv.Dr.Del.Rev.2005; 57: 391-410.
6. Bilati U, Allemann E, Doellkar E.Strategic approaches for overcoming peptide and protein stability with in biodegradable nano and microparticles.Euro.J.Pharm.2005; 59: 375-388.
7. Amorij JP, Saluja V, Petersen AH, Hinrichs WLJ, Huckriede A, Frijlink HW.Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.Vaccine, 2007; 2: 8707-8717.
8. Raghuvanshi RS, Goyal S, Singh Om, Panda AK.Stabilization of dichloromethane-induced protein denaturation during microencapsulation.Pharm. Dev.Technol.1998; 3: 269-276.
9. Perez C, Montano N, Gonzalez K, Griebenow K.Stabilization of alpha-chymotrypsin at the CH2Cl2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres.J.Cont.Rel.2003; 89: 71-85.
10. Jaganathan KS, Vyas SP.Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally.Vaccine, 2006; 24(19): 4201-4211.
11. Sah HK, Toddywala R, Chien YW.Biodegradable microcapsules prepared by a w/o/w-technique: effects of shear force to make a primary w/o emulsion on their morphology and protein release.J.Microencap.1995; 12: 56-69.
12. Sah H.Stabilization of proteins against methylene chloride/ water interface-induced denaturation and aggregation.J.Contr.Rel.1999; 58: 143-151.
13. Uchida T, Shiosaki K, Nakada Y, Fukada K, Eda Y, Tokiyoshi S, Nagareya N, Matsuyama K.Microencapsulation of hepatitis B core antigen for vaccine preparation.Pharm.Res.1998;15:1708-1713.
14. Ingrid Castellanos J, Ruben C, Kai G.Encapsulation-induced aggregation and loss in activity of (-chymotrypsin and their prevention.J.Cont.Rel.2002; 81: 307-319.
15. Ingrid Castellanos J, Wanda L, Cuadrado Kai G.Prevention of structural perturbations and aggregation upon encapsulation of bovine serum albumin into poly(lactide-co-glycolide) microspheres using the solid-in-oil-in-water technique.J.Pharm.Pharmacol.2001; 53: 1099-1107.
16. Carrasquillo KG, Cordero RA, HO S, Franquiz JM, Griebenow K.Structure-guided encapsulation of bovine serum albumin in poly(DL-lactic-co- glycolic)acid.Pharm.Pharmacol.Commun.1998; 4: 563-571.
17. McGee JP, Singh M, Li XM, Qiu H, Hagan O.The encapsulation of a model protein in poly(D,L lactide-co-.glycolide) microparticles of various sizes: an evaluation of preservation of process reproducibility.J.Microencap.1997; 14: 197-210.
18. Cuervo ML, Sterling AL, Nicot IA, Rodríguez MG, García OR.Validation of a new alternative for determining in vitro potency in vaccines containing Hepatitis B from two different manufacturers.Biologicals 2008; 36(6): 375-382.
19. Morlock M, Koll H, Winter G, Kissel T.Microencapsulation of rh-erythropoietin, using biodegradable poly (DL-lactide-coglycolide): protein stability and the effects of stabilizing excipients.Eur.J.Pharm.Biopharm.1997; 43: 29-36.
20. Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Yang J,Nagai T.Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine using PLGA microspheres.J.Cont.Rel.2006; 112 (2): 35-42.
21. Hagan Derek TO, Singh M, Gupta RK.Poly (lactide-co-glycolide) microparticles for the development of single-dose controlledrelease vaccines.Adv.Dr.Del.Rev.1998; 32: 225-246.
22. Jilie K, Shaoning YU.Fourier Transform Infrared Spectroscopic Analysis of Protein Secondary Structures.Act.Biochim.Biophys.Sin.2007; 39: 549-559.
23. Griebenow K, Santos AM, Carrasquillo KG.Secondary structure of proteins in the amorphous dehydrated state probed by FTIR spectroscopy.Dehydration- induced structure al changes and their prevention.Internet J.Vibr.Spec.[www. ijvs.com] 1999; 3(1): 3-11.
24. Kelly M, Sharon J, Thomas J, Price NC.How to study proteins by circular dichorism.Biochim.Biophy.Act.2005; 1751: 119- 139.
25. Jorgensen L, Vermehren C, Bjerregaard S, Froekjaer S.Secondary structure alterations in insulin and growth hormone water-in-oil emulsions.Int.J.Pharm. 2003; 254: 7-10.
26. Jaganathan KS, Singh P, Prabhakaran D, Mishra V, Vyas SP.Development of a single-dose stabilized poly (D, L-lactic-coglycolic acid) microspheres based vaccine against hepatitis-B.J.Pharm.Pharmacol.2004; 56: 1243-125.